REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Pharmaapoyo Cia.Ltda (Ecuador)

Main Activities: Pharmaceutical and Medicine Manufacturing
Secondary Activities: Medicinal and Botanical Manufacturing
Full name: Pharmaapoyo Cia.Ltda Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Pharmaapoyo Cia.Ltda is based in Ecuador, with the head office in Quito. The company operates in the Pharmaceutical and Medicine Manufacturing industry. The company was established on April 11, 2016. The total number of employees is currently 5 (2021). In 2022, the company reported a net sales revenue drop of 3.8%. Its’ total assets recorded a negative growth of 17.49%. The net profit margin of Pharmaapoyo Cia.Ltda increased by 0.47% in 2022.

Headquarters
Bellavista Oe3-478, Edificio Platinum Bldg. , Floor 1
Quito; Pichincha;

Contact Details: Purchase the Pharmaapoyo Cia.Ltda report to view the information.

Basic Information
Total Employees:
Purchase the Pharmaapoyo Cia.Ltda report to view the information.
Outstanding Shares:
Purchase the Pharmaapoyo Cia.Ltda report to view the information.
Registered Capital:
Purchase the Pharmaapoyo Cia.Ltda report to view the information.
Incorporation Date:
April 11, 2016
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
99%
Purchase this report to view the information.
1%
Company Performance
Financial values in the chart are available after Pharmaapoyo Cia.Ltda report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-3.8%▼
Total operating revenue
-4.5%▼
Operating profit (EBIT)
708.87%▲
EBITDA
286.88%▲
Net Profit (Loss) for the Period
142.05%▲
Total assets
-17.49%▼
Total equity
23.38%▲
Operating Profit Margin (ROS)
4.49%▲
Net Profit Margin
0.47%▲
Return on Equity (ROE)
9.29%▲
Debt to Equity Ratio
-283.73%▼
Quick Ratio
0.05%▲
Cash Ratio
0.07%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo